Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacist-only PSE sales in Louisiana

This article was originally published in The Tan Sheet

Executive Summary

A law requiring sales of OTC drugs containing ephedrine, pseudoephedrine and phenylpropanolamine to be done by licensed pharmacists takes effect Aug. 15. Louisiana lawmakers this year enacted the law, which requires retailers to conduct electronic logging of transactions, to curb illicit methamphetamine production by controlling access to precursors. Oregon already has moved PSE- and ephedrine-containing products to Rx-status and legislation is pending in California to make the products prescription only (1"The Tan Sheet" June 8, 2009, In Brief)

You may also be interested in...



California Senate weighs Rx PSE

The California Senate's Appropriations Committee May 28 approves a bill making it illegal in the state to buy ephedrine- or pseudophedrine-containing products without a prescription. The Consumer Healthcare Products Association initiated an Internet campaign against the bill's passage, warning California consumers they could lose OTC access to antihistamine and decongestant products such as Zyrtec-D, Sudafed and Claritin-D. The trade group notes the state would incur costs from increased health insurance premiums for state employees and could lose $4.5 million in sales tax revenue if ephedrine and PSE products become Rx-only. CHPA argues that existing federal law and electronic logbooks to monitor purchases of methamphetamine precursors have helped decrease the number of illicit meth labs. Oregon so far is the only state to enact a prescription-only law for all PSE drugs (1"The Tan Sheet" Feb. 23, 2009, p. 3)

Arena Cannabinoid Pain Compound Misses In Phase IIb IBS Trial

Arena's Phase IIb CAPTIVATE trial assessing investigational olorinab in IBS missed its primary endpoint.

More Encouraging Real World Data From UK – But Can It Turn Around European Sentiment On AZ COVID-19 Vaccine?

Another real-world study from the UK’s rapid vaccine rollout provides evidence that Pfizer’s vaccine saves lives, with the AZ shot matching it on cutting hospitalizations.

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel